Growth Metrics

Neuroone Medical Technologies (NMTC) Debt to Equity (2016 - 2024)

Neuroone Medical Technologies filings provide 7 years of Debt to Equity readings, the most recent being $0.03 for Q1 2024.

  • On a quarterly basis, Debt to Equity changed N/A to $0.03 in Q1 2024 year-over-year; TTM through Mar 2024 was $0.03, a N/A change, with the full-year FY2023 number at $0.02, changed N/A from a year prior.
  • Debt to Equity hit $0.03 in Q1 2024 for Neuroone Medical Technologies, up from $0.02 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.03 in Q1 2024 to a low of $0.02 in Q3 2023.